CIP2A and acute myeloid leukemia: Altogether, our results demonstrate that MYC activates the expression of TFs such as SP1, forming a complex that enhances the transcription of SET, and eventually, the expression of CIP2A and SETBP1, resulting in PP2A inactivation and increasing cell proliferation in AML.